157 related articles for article (PubMed ID: 6140313)
1. Innovations in peptic ulcer disease: histamine 2-receptor antagonists.
Romankiewicz N
J Pract Nurs; 1983; 33(8):8-9. PubMed ID: 6140313
[No Abstract] [Full Text] [Related]
2. [Treatment of peptic ulcer with histamine H2-receptor antagonists].
Radbil' OS
Sov Med; 1977 Nov; (11):111-9. PubMed ID: 24276
[No Abstract] [Full Text] [Related]
3. [Therapy of peptic ulcer. H2 receptor blockers].
Domschke W
Verh Dtsch Ges Inn Med; 1988; 94():272-5. PubMed ID: 2905101
[No Abstract] [Full Text] [Related]
4. [Antacids, histamine H2 receptor antagonists].
Raphaël M
Soins; 1988 Apr; (511):I-II. PubMed ID: 2899911
[No Abstract] [Full Text] [Related]
5. [A gastroenterologist's choice: proton pump inhibitors of H2 histamine receptor blockers in the treatment of peptic ulcer].
Morozov IA
Klin Med (Mosk); 2001; 79(5):68-71. PubMed ID: 11510196
[No Abstract] [Full Text] [Related]
6. Pharmacology update. Anti-peptic ulcer agents--Part I. A histamine 2 receptor antagonist.
Romankiewicz JA
J Pract Nurs; 1981 Jan; 31(1):15-6. PubMed ID: 6108367
[No Abstract] [Full Text] [Related]
7. [H2 blockers and acute peptic ulcer].
Müller P; Dammann HG; Simon B
Fortschr Med; 1986 Dec; 104(3):903-7. PubMed ID: 2881861
[No Abstract] [Full Text] [Related]
8. Histamine2-receptor antagonists. Standard therapy for acid-peptic diseases (2).
Feldman M; Burton ME
N Engl J Med; 1990 Dec; 323(25):1749-55. PubMed ID: 1978926
[No Abstract] [Full Text] [Related]
9. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage I-II preparations in the therapy of internal diseases].
Grebnev AL; Miagkova LP; Kkhorshed AM
Klin Med (Mosk); 1991 Mar; 69(3):23-7. PubMed ID: 1676772
[No Abstract] [Full Text] [Related]
10. [What is the role of H2 receptor blockers today in ulcer therapy?].
Creutzfeldt W
Internist (Berl); 1996 Sep; 37(9):937-8. PubMed ID: 8964690
[No Abstract] [Full Text] [Related]
11. [Peptic ulcer: how to treat it long term].
Zaterka S; Bettarello A
Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(1):1-3. PubMed ID: 2892245
[No Abstract] [Full Text] [Related]
12. [Opinion on the drug treatment of peptic ulcer].
Tarpila S
Duodecim; 1991; 107(22):1906-7. PubMed ID: 1365972
[No Abstract] [Full Text] [Related]
13. Histamine H2-receptor antagonists and peptic ulcer disease.
Thompson MH
South Med J; 1978 Jul; 71(7):753. PubMed ID: 26979
[No Abstract] [Full Text] [Related]
14. [New therapeutic possibilities in peptic ulcer].
Schraier M
Acta Gastroenterol Latinoam; 1980; 10(4):325-7. PubMed ID: 6115534
[No Abstract] [Full Text] [Related]
15. [The use of histamine H2 receptor blockaders in gastroenterology].
Waldum HL; Petersen H
Tidsskr Nor Laegeforen; 1983 Apr; 103(12):980-3. PubMed ID: 6136102
[No Abstract] [Full Text] [Related]
16. Drug therapy of peptic ulcer disease.
Ching CK; Lam SK
Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of tolerance to peptic ulcer healing and relapse.
Misiewicz JJ
Aliment Pharmacol Ther; 1990; 4 Suppl 1():85-96. PubMed ID: 1983350
[No Abstract] [Full Text] [Related]
18. The impact of H2-receptor antagonists on the complications, morbidity and mortality of peptic ulcer disease.
Isenberg JI
Aliment Pharmacol Ther; 1987; 1 Suppl 1():447S-454S. PubMed ID: 2908766
[TBL] [Abstract][Full Text] [Related]
19. Eradication treatment for Helicobacter pylori in general practice.
Fraser AG; Moore L; Berry S; Arroll B
N Z Med J; 1996 Nov; 109(1033):422-4. PubMed ID: 8941293
[TBL] [Abstract][Full Text] [Related]
20. Satellite symposium: New therapeutic approach to peptic ulcer disease. 34th annual meeting of the Japanese Society of Gastroenterology.
Gastroenterol Jpn; 1993 May; 28 Suppl 5():191-201. PubMed ID: 8103024
[No Abstract] [Full Text] [Related]
[Next] [New Search]
